FDA Must Have Compelling Reason To Deny Advisory Review Request- PhRMA
Executive Summary
FDA must present a compelling argument for denial of a sponsor's request for an advisory committee review of an unresolved scientific dispute with the agency, the Pharmaceutical Research & Manufacturers of America said in comments on FDA's draft guidance for formal dispute resolution.